Evolution of antiretroviral drug rilpivirine and approach to oncology

HIGHLIGHTS

  • who: Mariana Pereira and Nuno Vale from the Institute of Biomedical Sciences Abel Salazar (ICBAS), Universidade do (UP), have published the paper: Evolution of Antiretroviral Drug Rilpivirine and Approach to Oncology, in the Journal: (JOURNAL)
  • what: For this review, the results of interest are the ones obtained for rilpivirine alone. This study demonstrated that rilpivirine has antineoplastic activity in several cell lines associated with multiple types of cancer, making this drug an interesting candidate for drug repurposing . The study proposed to find from a database with thousands of drugs a possible repurposed drug that could . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?